1. Home
  2. TDS vs TMDX Comparison

TDS vs TMDX Comparison

Compare TDS & TMDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Telephone and Data Systems Inc.

TDS

Telephone and Data Systems Inc.

HOLD

Current Price

$43.18

Market Cap

5.5B

ML Signal

HOLD

Logo TransMedics Group Inc.

TMDX

TransMedics Group Inc.

HOLD

Current Price

$105.07

Market Cap

4.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TDS
TMDX
Founded
1968
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Telecommunications Equipment
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Sector
Telecommunications
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.5B
4.6B
IPO Year
N/A
2019

Fundamental Metrics

Financial Performance
Metric
TDS
TMDX
Price
$43.18
$105.07
Analyst Decision
Strong Buy
Buy
Analyst Count
3
9
Target Price
$53.33
$154.00
AVG Volume (30 Days)
647.4K
990.7K
Earning Date
05-01-2026
05-07-2026
Dividend Yield
0.37%
N/A
EPS Growth
N/A
382.18
EPS
N/A
4.87
Revenue
N/A
$605,494,000.00
Revenue This Year
$4.05
$24.51
Revenue Next Year
$1.72
$18.73
P/E Ratio
N/A
$21.57
Revenue Growth
N/A
37.13
52 Week Low
$31.07
$62.42
52 Week High
$47.80
$156.00

Technical Indicators

Market Signals
Indicator
TDS
TMDX
Relative Strength Index (RSI) 45.32 30.56
Support Level $36.76 $99.95
Resistance Level $45.02 $131.86
Average True Range (ATR) 1.18 5.92
MACD -0.05 -2.39
Stochastic Oscillator 53.33 8.93

Price Performance

Historical Comparison
TDS
TMDX

About TDS Telephone and Data Systems Inc.

Telephone and Data Systems Inc is a diversified telecommunications operator that provides mobile, telephone, and broadband services. The company's segments include UScellular Wireless, UScellular Towers, and TDS Telecom. It generates maximum revenue from the UScellular Wireless segment.

About TMDX TransMedics Group Inc.

TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System(OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The Company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.

Share on Social Networks: